GPT and metabolic dysfunction-associated steatotic liver disease: In a cohort of 217 Chinese patients with biopsy-proven NAFLD, Sun et al. [49] found that patients with NAFLD and persistently normal ALT levels were more likely to have higher levels of glomerular and tubular damage biomarkers compared to their counterparts with abnormal ALT levels.